TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
DT Cloud Acquisition Corp. ( (DYCQ) ) has shared an update.
DT Cloud Acquisition Corporation and Maius Pharmaceutical Co., Ltd. have announced a definitive business combination agreement, setting the stage for Maius to become a wholly-owned subsidiary of a new holding company, Maius Pharmaceutical Group Co., Ltd., which will be listed on Nasdaq. With an equity value of $250 million, the merger focuses on expanding Maius’s innovative drug development in anticancer, autoimmune, and anti-infective areas. The transaction, expected to close in the first half of 2025, is subject to regulatory and shareholder approvals, promising exciting investment opportunities in the biopharmaceutical sector.
Learn more about DYCQ stock on TipRanks’ Stock Analysis page.